Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 483.53M P/E 46.62 EPS this Y -51.10% Ern Qtrly Grth -
Income -112.64M Forward P/E -2.55 EPS next Y -30.00% 50D Avg Chg -5.00%
Sales 12.6M PEG - EPS past 5Y - 200D Avg Chg -20.00%
Dividend N/A Price/Book 0.74 EPS next 5Y - 52W High Chg -51.00%
Recommedations 1.60 Quick Ratio 13.46 Shares Outstanding 35.84M 52W Low Chg 8.00%
Insider Own 0.54% ROA -12.97% Shares Float 24.79M Beta 1.15
Inst Own 102.36% ROE -18.19% Shares Shorted/Prior 1.80M/1.73M Price 13.52
Gross Margin 100.00% Profit Margin - Avg. Volume 284,985 Target Price 36.25
Oper. Margin -1,171.69% Earnings Date May 8 Volume 250,232 Change -2.10%
About iTeos Therapeutics, Inc.

Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients with cancer. The company's lead antibody product candidate, belrestotug, an antagonist of TIGIT or T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial, as well as used to engage the Fc gamma receptor, or Fc?R to activate dendritic cells, natural killer cells, and macrophages and to promote antibody-dependent cellular cytotoxicity, or ADCC activity. Its product pipeline also includes inupadenant, a next-generation A2AR antagonists that is in Phase 1/2a clinical trials to overcome the specific adenosine-mediated immunosuppression found in tumor microenvironment; and EOS-984, a small molecule targeting equilibrative nucleoside transporter 1 (ENT1) to inhibit the immunosuppressive activity of adenosine and restore immune cell proliferation is in Phase 1 clinical trials. Iteos Therapeutics, Inc. was founded in 2011 and is headquartered in Watertown, Massachusetts.

iTeos Therapeutics, Inc. News
03/06/24 iTeos Appoints Oncology Veteran Jill DeSimone to Its Board of Directors
03/06/24 iTeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
03/05/24 iTeos to Highlight Preclinical Data on First-In-Class EOS-984 Targeting ENT1 at the American Association for Cancer Research Annual Meeting 2024
03/01/24 iTeos to Participate in Upcoming Investor Conferences
02/26/24 Strength Seen in iTeos Therapeutics, Inc. (ITOS): Can Its 7.4% Jump Turn into More Strength?
01/08/24 iTeos Announces 2024 Strategic Priorities and Anticipated Milestones
01/03/24 iTeos to Present at the 42nd Annual J.P. Morgan Healthcare Conference
12/13/23 Wall Street Analysts Believe iTeos Therapeutics, Inc. (ITOS) Could Rally 243.43%: Here's is How to Trade
11/27/23 Does iTeos Therapeutics, Inc. (ITOS) Have the Potential to Rally 283.59% as Wall Street Analysts Expect?
11/21/23 iTeos to Present at the Piper Sandler 35th Annual Healthcare Conference
11/13/23 Here's Why iTeos Therapeutics, Inc. (ITOS) Could be Great Choice for a Bottom Fisher
11/10/23 Wall Street Analysts Predict a 304.26% Upside in iTeos Therapeutics, Inc. (ITOS): Here's What You Should Know
11/07/23 iTeos Reports Third Quarter 2023 Financial Results and Provides Business Updates
10/31/23 Viridian Therapeutics, Inc. (VRDN) Stock Jumps 5.2%: Will It Continue to Soar?
10/16/23 iTeos Therapeutics, Inc. (ITOS) Stock Jumps 5.4%: Will It Continue to Soar?
10/11/23 NCR Atleos Set to Join S&P SmallCap 600
08/24/23 Biotech Stocks Rally After Roche's (RHHBY) Accidental Data Leak
08/23/23 Why Roche's Accidental Cancer Update Boosted Several Rivals By As Much As 22%
08/08/23 iTeos Reports Second Quarter 2023 Financial Results and Provides Business Updates
05/13/23 Broker Revenue Forecasts For iTeos Therapeutics, Inc. (NASDAQ:ITOS) Are Surging Higher
ITOS Chatroom

User Image JackDarwin Posted - 7 hours ago

$ITOS Nice Gap Up With Good Volume.

User Image FonsieTrader Posted - 14 hours ago

$ITOS Heading higher for $18

User Image vu_jade Posted - 1 day ago

$ITOS decent speculation

User Image ozzy790 Posted - 1 week ago

$ITOS Im in at 10.75

User Image Turkeycock Posted - 2 weeks ago

$ITOS strong

User Image ozzy790 Posted - 2 weeks ago

$ITOS jumping in at 11$

User Image vu_jade Posted - 3 weeks ago

$ITOS looks like great spot

User Image stockpicker63 Posted - 3 weeks ago

Watch today! $SE, $PSTG, $DXCM and $ITOS

User Image DonCorleone77 Posted - 3 weeks ago

$ITOS iTeos Therapeutics reports Q4 EPS (85c), consensus ($1.03) "As we anticipate four clinical readouts across the portfolio, 2024 is poised to be a transformative year for iTeos," said Michel Detheux, Ph.D., president and chief executive officer of iTeos. "With the recent developments in the TIGIT field, we believe belrestotug is in an advantageous position and are excited for its future prospects. We look forward to sharing updates from our Phase 2 trials focused on 1L NSCLC and 1L HNSCC in 2024. Additionally, our strong comprehension of the adenosine pathway has enabled us to develop two innovative and optimized assets - inupadenant, an A2AR antagonist in a class of its own, and EOS-984, a potential first-in-class inhibitor targeting the novel mechanism of ENT1. With our strategic cash position and robust pipeline, we are focused on the execution of these clinical trials to deliver on our highly anticipated milestones this year."

User Image Stock_Titan Posted - 3 weeks ago

$ITOS iTeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates https://www.stocktitan.net/news/ITOS/i-teos-reports-fourth-quarter-and-full-year-2023-financial-results-a04p80plfcmt.html

User Image Stock_Titan Posted - 3 weeks ago

$ITOS iTeos to Highlight Preclinical Data on First-In-Class EOS-984 Targeting ENT1 at the American Association for Cancer Research Annual Meeting 2024 https://www.stocktitan.net/news/ITOS/i-teos-to-highlight-preclinical-data-on-first-in-class-eos-984-bqxkb35ojylc.html

User Image Stock_Titan Posted - 3 weeks ago

$ITOS iTeos to Participate in Upcoming Investor Conferences https://www.stocktitan.net/news/ITOS/i-teos-to-participate-in-upcoming-investor-zlw7g0hfi21b.html

User Image StockInvest_us Posted - 4 weeks ago

Signal alert: $ITOS - PivotPoint bottom https://stockinvest.us/l/is5tVDm4cM

User Image shared_alerts Posted - 1 month ago

-02/23/2024- 📉 SCANNER UPDATE📈 $NVAX $ITOS $TARS $PHAT ↩️

User Image BukuBuKzII Posted - 1 month ago

$IOVA $INZY $ITOS 2024 is all about the I-ticker biotech stocks!!! Big money to be made in the foregoing. Do your DD and thank me later!!

User Image Will2ride1 Posted - 1 month ago

$ITOS yeah...bully

User Image cctranscripts Posted - 2 months ago

BlackRock, Inc. just provided an update on share ownership of iTeos Therapeutics, Inc. https://www.conferencecalltranscripts.org/summary/?id=12887947 $ITOS

User Image tickeron Posted - 2 months ago

Is this good for your portfolio? $ITOS entered a Downtrend because Momentum Indicator dropped below the 0 level. View odds of downtrend. https://srnk.us/go/4972350

User Image risenhoover Posted - 2 months ago

$ITOS / iTeos Therapeutics files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 https://fintel.io/doc/sec-iteos-therapeutics-inc-1808865-8k-2024-january-10-19732-7350?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image Last10K Posted - 2 months ago

$ITOS just filed with the SEC a Regulated Disclosure and a Financial Exhibit https://last10k.com/sec-filings/ITOS/0000950170-24-003664.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=ITOS

User Image cctranscripts Posted - 2 months ago

iTeos Therapeutics, Inc. just filed its Current report, items 7.01 and 9.01 http://www.sec.gov/Archives/edgar/data/1808865/000095017024003664/0000950170-24-003664-index.htm $ITOS

User Image cctranscripts Posted - 2 months ago

Israel A. Englander just provided an update on share ownership of iTeos Therapeutics, Inc. https://www.conferencecalltranscripts.org/summary/?id=12854491 $ITOS

User Image UltraAlgo Posted - 2 months ago

$ITOS Sell Rating based off 6 signals, 15-min chart. 💸 Algo Trading at UltraAlgo https://i.redd.it/8ffz5shm5bac1.png

User Image Stock_Titan Posted - 2 months ago

$ITOS iTeos Announces 2024 Strategic Priorities and Anticipated Milestones https://www.stocktitan.net/news/ITOS/i-teos-announces-2024-strategic-priorities-and-anticipated-9m5mlxz234bb.html

User Image UltraAlgo Posted - 2 months ago

$ITOS Sell Rating based off 6 signals on the 15-min chart. #ITOS 🚀 Chart by UltraAlgo.com https://i.redd.it/uctkjsbx64ac1.png

User Image Stock_Titan Posted - 2 months ago

$ITOS iTeos to Present at the 42nd Annual J.P. Morgan Healthcare Conference https://www.stocktitan.net/news/ITOS/i-teos-to-present-at-the-42nd-annual-j-p-morgan-healthcare-vqqne5jtl88d.html

User Image StockAutomatePro Posted - 2 months ago

$ITOS The chart is pointing towards a potential rise in the stock price. We alerted the BUY signal at $10.86 and we were able to close this one with profit at $11.59 🔏

User Image tickeron Posted - 2 months ago

Do you agree with the A.I. prediction? $ITOS entered a Downtrend because Momentum Indicator dropped below the 0 level. View odds of downtrend. https://srnk.us/go/4953496

User Image StockAutomatePro Posted - 3 months ago

$ITOS Stock may be in for a substantial increase based on the chart. We alerted the BUY signal at $9.83 and we were able to close this one with profit at $10.991 🥳

User Image StockAutomatePro Posted - 3 months ago

$ITOS Stock is looking strong based on the chart. We alerted the BUY signal at $9.78 and we were able to close this one with profit at $10.89 🥳

Analyst Ratings
JP Morgan Overweight Mar 12, 24
HC Wainwright & Co. Buy Mar 7, 24
JP Morgan Overweight Nov 13, 23
Wedbush Outperform Oct 18, 23
HC Wainwright & Co. Buy Aug 9, 23
HC Wainwright & Co. Buy Mar 17, 23
JP Morgan Overweight Mar 16, 23
Wedbush Outperform Mar 16, 23
SVB Leerink Outperform May 13, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Gall Matthew Chief Financial Offi.. Chief Financial Officer Oct 12 Buy 8.37 5,000 41,850 19,429 10/12/23
Boxer Capital, LLC Other Other Aug 23 Sell 15.56 350,000 5,446,000 1,804,058 08/25/23
Call Matthew Chief Operating Offi.. Chief Operating Officer Mar 28 Option 2.95 40,226 118,667 93,898 03/29/23
Hallal David Director Director Jun 08 Option 3.91 29,615 115,795 1,171 06/10/22
Hallal David Director Director Jun 08 Sell 20.04 29,615 593,485 06/10/22
Davis Aaron I. Director Director May 09 Sell 22.02 663,000 14,599,260 2,154,058 05/11/22
Davis Aaron I. Director Director Apr 28 Sell 27.41 375,000 10,278,750 2,817,058 05/02/22
Detheux Michel Chief Executive Offi.. Chief Executive Officer Apr 18 Option 4.23 11,500 48,645 37,763 04/19/22
Detheux Michel Chief Executive Offi.. Chief Executive Officer Apr 18 Sell 32.26 11,500 370,990 26,263 04/19/22
Davis Aaron I. Director Director Mar 22 Buy 32.81 50,000 1,640,500 3,192,058 03/24/22
Detheux Michel Chief Executive Offi.. Chief Executive Officer Mar 21 Sell 34.82 18,437 641,976 26,263 03/22/22
Boxer Capital, LLC 10% Owner 10% Owner Mar 17 Sell 35.25 575,201 20,275,835 3,142,058 03/18/22
Lager Joanne Jenkins Chief Medical Office.. Chief Medical Officer Mar 11 Option 4.3 3,500 15,050 3,500 03/14/22
Lager Joanne Jenkins Chief Medical Office.. Chief Medical Officer Mar 11 Sell 36.01 3,500 126,035 03/14/22
McGrath Yvonne Chief Scientific Off.. Chief Scientific Officer Mar 01 Option 4.24 10,000 42,400 10,000 03/02/22
McGrath Yvonne Chief Scientific Off.. Chief Scientific Officer Mar 01 Sell 36.76 10,000 367,600 03/02/22
Detheux Michel Chief Executive Offi.. Chief Executive Officer Feb 23 Sell 34.81 14,500 504,745 34,700 02/24/22
Lager Joanne Jenkins Chief Medical Office.. Chief Medical Officer Feb 11 Option 4.3 3,500 15,050 3,500 02/14/22
Lager Joanne Jenkins Chief Medical Office.. Chief Medical Officer Feb 11 Sell 35.9 3,500 125,650 02/14/22
Detheux Michel Chief Executive Offi.. Chief Executive Officer Jan 25 Sell 35.83 14,500 519,535 49,200 01/26/22
Lager Joanne Jenkins Chief Medical Office.. Chief Medical Officer Jan 14 Option 4.3 3,500 15,050 3,500 01/18/22
Lager Joanne Jenkins Chief Medical Office.. Chief Medical Officer Jan 14 Sell 39.42 3,500 137,970 01/18/22
Boxer Capital, LLC Director Director Jan 03 Sell 46.11 700,000 32,277,000 01/05/22
Lager Joanne Jenkins Chief Medical Office.. Chief Medical Officer Jan 03 Option 4.3 7,000 30,100 7,000 01/04/22
Lager Joanne Jenkins Chief Medical Office.. Chief Medical Officer Jan 03 Sell 51.9 7,000 363,300 01/04/22
Detheux Michel Chief Executive Offi.. Chief Executive Officer Dec 02 Option 4.3 30,000 129,000 79,863 12/22/21
Detheux Michel Chief Executive Offi.. Chief Executive Officer Dec 02 Sell 44.62 44,500 1,985,590 63,700 12/22/21
Hallal David Director Director Dec 20 Option 3.63 50,000 181,500 50,000 12/22/21
Hallal David Director Director Dec 20 Sell 43.57 50,000 2,178,500 12/22/21
Lager Joanne Jenkins Chief Medical Office.. Chief Medical Officer Dec 17 Option 4.3 7,000 30,100 7,000 12/17/21
Lager Joanne Jenkins Chief Medical Office.. Chief Medical Officer Dec 17 Sell 41 7,000 287,000 12/17/21
Lager Joanne Jenkins Chief Medical Office.. Chief Medical Officer Dec 10 Option 4.3 3,500 15,050 3,500 12/10/21
Lager Joanne Jenkins Chief Medical Office.. Chief Medical Officer Dec 10 Sell 34.5 3,500 120,750 12/10/21
MPM BIOVENTURES 2018, L.P. 10% Owner 10% Owner Dec 03 Sell 34.3 49,831 1,709,203 2,885,470 12/07/21
MPM BioVentures 2014, L.P. 10% Owner 10% Owner Dec 03 Sell 34.3 49,831 1,709,203 2,885,470 12/07/21
GADICKE ANSBERT 10% Owner 10% Owner Dec 03 Sell 34.3 83,390 2,860,277 4,730,197 12/07/21
MPM BIOVENTURES 2018, L.P. 10% Owner 10% Owner Nov 30 Sell 34.59 83,519 2,888,922 2,935,301 12/02/21
MPM BioVentures 2014, L.P. 10% Owner 10% Owner Nov 30 Sell 34.59 83,519 2,888,922 2,935,301 12/02/21
GADICKE ANSBERT 10% Owner 10% Owner Nov 30 Sell 34.59 139,773 4,834,748 4,813,587 12/02/21
MPM BIOVENTURES 2018, L.P. 10% Owner 10% Owner Nov 26 Sell 35.34 23,045 814,410 3,018,820 11/30/21
MPM BioVentures 2014, L.P. 10% Owner 10% Owner Nov 26 Sell 35.34 23,045 814,410 3,018,820 11/30/21
GADICKE ANSBERT 10% Owner 10% Owner Nov 26 Sell 35.34 38,566 1,362,922 4,953,360 11/30/21
Detheux Michel Chief Executive Offi.. Chief Executive Officer Nov 22 Option 12.45 16,263 202,474 92,700 11/24/21
Detheux Michel Chief Executive Offi.. Chief Executive Officer Nov 22 Sell 36.08 14,500 523,160 78,200 11/24/21
GADICKE ANSBERT 10% Owner 10% Owner Nov 17 Sell 36.56 129,617 4,738,798 4,991,926 11/24/21
MPM BIOVENTURES 2018, L.P. 10% Owner 10% Owner Nov 17 Sell 36.56 77,455 2,831,755 3,041,865 11/24/21
Lager Joanne Jenkins Chief Medical Office.. Chief Medical Officer Nov 18 Option 4.3 28,000 120,400 28,000 11/19/21
Lager Joanne Jenkins Chief Medical Office.. Chief Medical Officer Nov 18 Sell 34.5 28,000 966,000 11/19/21
Detheux Michel Chief Executive Offi.. Chief Executive Officer Oct 15 Sell 28.01 1,836 51,426 97,190 10/19/21
MPM BIOVENTURES 2018, L.P. 10% Owner 10% Owner Oct 15 Sell 27.56 17,099 471,248 3,134,991 10/18/21